Trials / Completed
CompletedNCT01601080
An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device
REbiSmart™ Retrospective ADherencE Review (READER) An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 230 (actual)
- Sponsor
- Merck KGaA, Darmstadt, Germany · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational, retrospective, UK \& Ireland audit measuring patient adherence to Rebif® injections with the RebiSmart™ injection device. Data will be collected from Multiple Sclerosis (MS) patients who have been prescribed Rebif® and have been using the RebiSmart™ device for injection for a minimum of 24 months.
Conditions
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-10-01
- First posted
- 2012-05-17
- Last updated
- 2014-02-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01601080. Inclusion in this directory is not an endorsement.